GENFIT obtains non-dilutive financing of €11 million in the form of a State Guaranteed Loan
Lille, France; Cambridge, MA; June 24, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…
Pharmaceuticals, Biotechnology and Life Sciences
Lille, France; Cambridge, MA; June 24, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…
— Christopher J. DeRespino appointed acting CFO — — Peter Soparkar appointed COO — — Leone Patterson departs as president…
Findings Published in Nature Chemical Biology Support Clinical Development of RMC-5552, the Company’s First-in-Class, Phase 1/1b Bi-steric mTORC1-Selective InhibitorREDWOOD CITY,…
TERN-201 is a highly selective VAP-1 inhibitor intended to address chronic liver inflammation and fibrosis in NASH Sustained VAP-1 inhibition…
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.comSALINAS, Calif.,…
Sorrento received official EUA registration and product import license: COFEPRIS EUA registration number “OFICIO: CAS/10720/2021”.Sorrento is establishing its “Sorrento Mexico…
NANTES, France, June 24, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced that all the resolutions…
Top liver disease conference showcases positive clinical data from Yaqrit’s technologies Results from two trials presented at EASL1 International Liver…
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused…
Oculogica receives ground-breaking patent to assess CTE via its eye-tracking technology.NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) — Oculogica, a…